
Johnson & Johnson Research and Development Expenses 2012 …
Johnson & Johnson annual/quarterly research and development expenses history and growth rate from 2012 to 2025. Research and development expenses can be defined as an expense arising from …
Johnson & Johnson R&D expenditure 2005-2024| Statista
Feb 17, 2025 · In 2024, Johnson & Johnson spent more than 17 billion U.S. dollars on research and development. This is a significant increase compared to 2014 when the company spent 8.5 billion …
Johnson & Johnson Reports 2020 Fourth-Quarter and Full Year Results
Jan 26, 2021 · New Brunswick, N.J. (January 26, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2020.
JNJ | Johnson & Johnson Financial Statements - WSJ
Johnson & Johnson balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View JNJ financial statements in full.
R&D Expenses For Johnson & Johnson (JNJ) - finbox.com
Jan 2, 2022 · Johnson & Johnson reported r&d expenses of 14.746 B for the latest twelve months ending December 28, 2025 on its income statement. The tables below summarizes Johnson & …
Johnson & Johnson Research and Development Expense (Annual ... - YCharts
Dec 31, 2024 · In depth view into Johnson & Johnson Research and Development Expense (Annual) including historical data from 1990, charts and stats.
Financials - SEC filings | Johnson & Johnson - Investors
About us Our company Medicines & therapies Medical devices & technology Careers Investors Media Key links Terms of use Privacy statement Cookie policy Customize cookie settings Get in touch …
The top 10 pharma R&D budgets in 2020 - Fierce Biotech
Apr 6, 2021 · Merck was a real jumper this year, finally moving from third to displace J&J, who has been second to Roche for many years now. Spending $13.6 billion on its research in the year, a huge 37%...
Johnson & Johnson - Statistics & Facts | Statista
Dec 17, 2025 · Founded in 1886 in New Brunswick, New Jersey, Johnson & Johnson is one of the largest pharmaceutical and medical technology companies in the world. In 2024, the company …
Pharma’s top 20 R&D spenders in 2020 - Drug Discovery and …
May 13, 2021 · The company’s R&D expenses in 2020 grew by $1 billion due to costs linked to its BioNTech partnership and payments to the biopharma Myovant Sciences and infectious disease …